Alimentary mucositis: putting the guidelines into practice.
BACKGROUND
The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology completed an evidence-based review of the literature for the management of alimentary mucositis.


CONCLUSIONS
The present manuscript puts these guidelines into clinical practice by presenting two cases of alimentary mucositis from cancer therapy. These cases illustrate the impact of oral and gastrointestinal mucositis on patient care.
Brennan
Michael T
MT
Carolinas Medical Center, Charlotte, NC, USA, mike.brennan@carolinas.org
von Bültzingslöwen
Inger
I
Schubert
Mark M
MM
Keefe
Dorothy
D
D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D017281:Cost of Illness; D003967:Diarrhea / Q000209:etiology / Q000628:therapy; D004059:Diffusion of Innovation; D019317:Evidence-Based Medicine; D005260:Female; D005767:Gastrointestinal Diseases / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D019983:Guideline Adherence; D006801:Humans; D033181:Information Dissemination; D008297:Male; D008495:Medical Oncology / Q000379:methods* / Q000592:standards; D008875:Middle Aged; D052016:Mucositis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D009910:Oral Hygiene / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D012720:Severity of Illness Index; D013280:Stomatitis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*
D000970:Antineoplastic Agents